Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF STOCK OPTION ACTIVITY (Details)

v3.23.1
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]    
Weighted Average Exercise Price $ 0.67 $ 0.66
Number of Optioned Shares at beginning 1,590,000 1,640,000
Weighted Average Remaining Contractual Term in Years at beginning   2 years 9 months 29 days
Weighted Average Optioned Grant Date Fair Value at beginning $ 0.04 $ 0.04
Aggregate Intrinsic Value at beginning
Weighted Average Exercise Price, Granted
Number of Optioned Shares, Granted
Weighted Average Optioned Grant Date Fair Value, Granted
Weighted Average Exercise Price, Exercised
Number of Optioned Shares, Exercised
Weighted Average Optioned Grant Date Fair Value, Exercised
Weighted Average Exercise Price, Cancelled/expired $ 0.70 $ 0.60
Number of Optioned Shares , Canceled/expired (500,000) (50,000)
Weighted Average Optioned Grant Date Fair Value, Cancelled/expired $ 0.03 $ 0.19
Weighted Average Remaining Contractual Term in Years 1 year 10 months 28 days  
Weighted Average Exercise Price $ 0.65 $ 0.67
Number of Optioned Shares at ending 1,090,000 1,590,000
Weighted Average Remaining Contractual Term in Years, Vested and exercisable 1 year 6 months 18 days  
Weighted Average Optioned Grant Date Fair Value at ending $ 0.04 $ 0.04
Aggregate Intrinsic Value at ending
Weighted Average Exercise Price, Vested and exercisable $ 0.65  
Number of Optioned Shares, Vested and exercisable 1,090,000  
Weighted Average Optioned Grant Date Fair Value, Vested and exercisable $ 0.04  
Aggregate Intrinsic Value Vested and exercisable